Icon

BARHEMSYS (nda209510)- (5MG/2ML (2.5MG/ML),10MG/4ML (2.5MG/ML))

AMISULPRIDE ACACIA
5MG/2ML (2.5MG/ML),10MG/4ML (2.5MG/ML)
No Yes
2038-Feb-09 2025-Feb-26
None None
None No
BARHEMSYS is a dopamine-2 (D2) antagonist indicated in adults for: • Prevention of postoperative nausea and vomiting (PONV), either alone or in combination with an antiemetic of a different class. • Treatment of PONV in patients who have received antiemetic prophylaxis with an agent of a different class or have not received prophylaxis.
0 0 0
Total Other Developers None
Drugs with Suitability No
5MG/2ML (2.5MG/ML) ** ** - - -
10MG/4ML (2.5MG/ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.